Cargando…
P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429370/ http://dx.doi.org/10.1097/01.HS9.0000969212.99205.d9 |
_version_ | 1785090695856390144 |
---|---|
author | Zhang, Jian Song, Baoquan Kong, Xin Liu, Yin Yang, Hanlin Qiu, Huiying Wu, Depei |
author_facet | Zhang, Jian Song, Baoquan Kong, Xin Liu, Yin Yang, Hanlin Qiu, Huiying Wu, Depei |
author_sort | Zhang, Jian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104293702023-08-17 P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX Zhang, Jian Song, Baoquan Kong, Xin Liu, Yin Yang, Hanlin Qiu, Huiying Wu, Depei Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429370/ http://dx.doi.org/10.1097/01.HS9.0000969212.99205.d9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Zhang, Jian Song, Baoquan Kong, Xin Liu, Yin Yang, Hanlin Qiu, Huiying Wu, Depei P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX |
title | P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX |
title_full | P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX |
title_fullStr | P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX |
title_full_unstemmed | P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX |
title_short | P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX |
title_sort | p577: efficacy of selinexor combined with a hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia in patients exposed to venetoclax |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429370/ http://dx.doi.org/10.1097/01.HS9.0000969212.99205.d9 |
work_keys_str_mv | AT zhangjian p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax AT songbaoquan p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax AT kongxin p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax AT liuyin p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax AT yanghanlin p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax AT qiuhuiying p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax AT wudepei p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax |